Napatree Capital LLC Has $318,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Napatree Capital LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 629 shares of the healthcare conglomerate’s stock after purchasing an additional 89 shares during the period. Napatree Capital LLC’s holdings in UnitedHealth Group were worth $318,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. M&T Bank Corp increased its stake in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC increased its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares during the period. Benjamin Edwards Inc. increased its stake in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after buying an additional 1,051 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $517.72 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50-day simple moving average is $510.19 and its 200 day simple moving average is $547.11. The company has a market cap of $473.57 billion, a P/E ratio of 33.40, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on UNH shares. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.